New Key Statistics Module, Z-Score and F-Score
OTCPK:KHTRF Key Ratios
| Market Cap $ M | 410.41 |
| Enterprise Value $ M | 339.44 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 56.53 |
| Forward PE Ratio | 40.70 |
| Price/Book | 0.75 |
| Price/Sales | 1.71 |
| Price/Free Cash Flow | 18.10 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 249.00 |
| EPS (TTM) $ | -0.15 |
| Beneish M-Score | -2.92 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 9.00 |
| y-y EBITDA Growth Rate % | -3.40 |
| EV-to-EBIT | -37.17 |
| EV-to-EBITDA | 11.94 |
| PEG | 6.28 |
| Shares Outstanding M | 101.21 |
| Net Margin (%) | -6.28 |
| Operating Margin % | 2.37 |
| Pre-tax Margin (%) | -7.01 |
| Quick Ratio | 2.43 |
| Current Ratio | 3.41 |
| ROA % (ttm) | -2.17 |
| ROE % (ttm) | -2.73 |
| ROIC % (ttm) | 1.01 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.72 |
KHTRF Number of Guru Trades
KHTRF Volume of Guru Trades
Gurus Latest Trades with OTCPK:KHTRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:KHTRF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Knight Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:KHTRF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers